Activity of ceftobiprole against Pseudomonas aeruginosa clinical isolates from Europe collected in 2005-2006

被引:0
|
作者
Davies, T.
Sahm, D.
Flamm, R.
Bush, K.
机构
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:S583 / S583
页数:1
相关论文
共 50 条
  • [41] Murepavadin activity tested against contemporary (2016-17) clinical isolates of XDR Pseudomonas aeruginosa
    Sader, Helio S.
    Flamm, Robert K.
    Dale, Glenn E.
    Rhomberg, Paul R.
    Castanheira, Mariana
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (09) : 2400 - 2404
  • [42] Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolates
    Cabassi, Clotilde Silvia
    Sala, Andrea
    Santospirito, Davide
    Alborali, Giovanni Loris
    Carretto, Edoardo
    Ghibaudo, Giovanni
    Taddei, Simone
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2017, 16
  • [43] Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolates
    Clotilde Silvia Cabassi
    Andrea Sala
    Davide Santospirito
    Giovanni Loris Alborali
    Edoardo Carretto
    Giovanni Ghibaudo
    Simone Taddei
    Annals of Clinical Microbiology and Antimicrobials, 16
  • [44] Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia
    Henderson, A.
    Tan, E.
    McCarthy, K. L.
    Paterson, D. L.
    PATHOLOGY, 2018, 50 (07) : 748 - 752
  • [45] Antimicrobial Activity of Tobramycin Against Respiratory Cystic Fibrosis Pseudomonas aeruginosa Isolates from Bulgaria
    Strateva, T.
    Petrova, G.
    Mitov, I.
    JOURNAL OF CHEMOTHERAPY, 2010, 22 (06) : 378 - 383
  • [46] Current susceptibility patterns for Streptococcus pneumoniae and Haemophilus influenzae isolates from Europe:: findings of the 2005-2006 GLOBAL Surveillance Program
    Jones, M.
    Brown, N.
    Draghi, D.
    Thornsberry, C.
    Sahm, D.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S181 - S181
  • [47] Mutations Drive Increased Elastase Activity in Pseudomonas Aeruginosa Clinical Isolates
    Fernandes, S. E.
    McElheny, C.
    Doi, Y.
    Nouraie, M.
    Lee, J.
    Jorth, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [48] Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens:: results from the SENTRY Antimicrobial Surveillance Program (2005-2006)
    Fritsche, Thomas R.
    Sader, Helio S.
    Jones, Ronald N.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 61 (01) : 86 - 95
  • [49] Superior activity of colistin against Pseudomonas aeruginosa clinical isolates, including multidrug-resistant isolates, from multiple infection sources from 2007 to 2009
    Hawser, Stephen P.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (06) : 587 - 587
  • [50] In vitro activity of delafloxacin against clinical isolates of Pseudomonas aeruginosa resistant to carbapenems in a stage prior to the clinical use of this drug
    Garcia-Rivera, Celia
    Navarro, Marta
    Parra, Monica
    Sanchez Bautista, Antonia
    Gomez, Inmaculada
    Ventero, Maria-Paz
    Carlos Rodriguez, Juan
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2024, 37 (01) : 104 - 105